Unlike other cancer charities, we do not place safe bets on well-known, established scientists. We seek emerging talent with bold innovative ideas, the rising stars of cancer research who are willing to take risks and are not daunted by the most complex scientific challenges.
THE VAST MAJORITY OF SCIENTISTS MAKE THEIR MOST IMPORTANT BREAKTHROUGHS IN THEIR 30S.
In fact, most Nobel Laureates conducted their award-winning science before age 40. However, today’s scientists typically do not receive independent support from the federal government (the primary funder of research in the US) until age 42 on average. And the federal government prefers safe, incremental research. We free top young researchers from this constraint and provide the funding they need to pursue their innovative ideas early in their careers.
WE TAKE A DIVERSIFIED APPROACH TO CANCER RESEARCH.
Damon Runyon focuses on all cancers, not just one specific type of cancer. Cancers need to be studied and treated on the basis of their specific molecular and genetic drivers, not by the organs in which they are found. Our scientists seek to understand the causes of cancer at the most fundamental level as a way to find the best targets for treatment, using the full array of scientific approaches and technologies. When the technologies do not exist, they create them.
OUR STRATEGY WORKS. OUR TRACK RECORD IS UNSURPASSED.
Since our founding in 1946, scientists supported by Damon Runyon have become many of the highest impact scientists in cancer research. They have been at the forefront of paradigm shifts in our understanding of cancer and the transformation of cancer therapy.